VANCOUVER, British Columbia and BOSTON, March 12, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering ...

VANCOUVER, British Columbia and BOSTON, March 12, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, ...

ON24 and the ON24 logo are trademarks owned by ON24 ... at 08:10 Alnylam to Webcast Presentation at Stifel 2025 Virtual CNS Forum Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, ...

Learn more about whether Blue Owl Capital Inc. or Stifel Financial Corp. is a better investment based on AAII's A+ Investor ...

Learn more about whether Invesco Ltd. or Stifel Financial Corp. is a better investment based on AAII's A+ Investor grades, ...

Stifel analyst Chris O’Cull lowered the firm’s price target on Papa John’s (PZZA) to $40 from $45 and keeps a Hold rating on the shares. The ...

Stifel lowered the firm’s price target on Blink Charging (BLNK) to $2 from $3.50 and keeps a Hold rating on the shares. Blink delivered Q4 ...

Fintel reports that on March 26, 2025, Stifel initiated coverage of Palvella Therapeutics (NasdaqCM:PVLA) with a Buy ...

Stifel Financial (NYSE:SF – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Thursday. SF has been the topic of a number of other ...

March 13 (Reuters) - Stifel Financial (SF.N), opens new tab was ordered by a Financial Industry Regulatory Authority arbitration panel to pay a family $132.5 million for misrepresenting the risk ...

Stifel Financial on Thursday said it has been ordered to pay $132 million connection with allegations regarding investment recommendations. The Financial Industry Regulatory Authority, a U.S.